Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L15 pseudogene 18 (RPL15P18) is a processed pseudogene that shares sequence similarity with the ribosomal protein L15 gene but does not encode a functional protein. Pseudogenes are genetic elements that arise from duplication or retrotransposition of functional genes but accumulate mutations that prevent expression of a functional protein product. RPL15P18 is one of several dispersed pseudogenes for ribosomal protein L15[2][13][11]. There is currently no evidence for a biological role, involvement in disease, or drug interactions for this pseudogene. RPL15P18 is not considered a therapeutic target and may be ignored for medicinal chemistry or pharmacology research purposes. Any use as a target or biomarker would be unsupported by current database and literature evidence[13][2][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L15 pseudogene 18 (RPL15P18).